Novo Nordisk A S NVO
NYSE NVO
$46.99 +0.85 (+1.84%)
As of: Aug 21, 2026 · 2:43 PM EDT

Novo Nordisk A S (NVO) Operating Expenses (2012 - 2016)

Novo Nordisk A S's (NVO) quarterly Operating Expenses came in at $638.0 million in Q2 2016, up 10.19% YoY from $579.0 million in Q3 2015, and up 2.57% on a QoQ basis from $622.0 million in Q1 2016.

Novo Nordisk A S (NVO) Operating Expenses (2012 - 2016) Analysis & Trends

Novo Nordisk A S (NVO) has 5 years of Operating Expenses data on file, last reported at $638.0 million in Q2 2016.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2016 638.00 Mn
Mar 31, 2016 622.00 Mn
Dec 31, 2015 764.00 Mn
Sep 30, 2015 633.00 Mn
Jun 30, 2015 579.00 Mn
Mar 31, 2015 620.00 Mn
Dec 31, 2014 833.00 Mn
Sep 30, 2014 806.00 Mn
Jun 30, 2014 712.00 Mn
Mar 31, 2014 729.00 Mn
Dec 31, 2013 841.00 Mn
Sep 30, 2013 642.00 Mn
Jun 30, 2013 619.00 Mn
Mar 31, 2013 612.00 Mn
Dec 31, 2012 729.00 Mn
Sep 30, 2012 569.00 Mn
Jun 30, 2012 576.00 Mn
Mar 31, 2012 579.00 Mn